medigraphic.com
Asociación Mexicana de Gastroenterología

2007, Number 1

<< Back Next >>

Rev Gastroenterol Mex 2007; 72 (1)

Association of depression and anxiety in patients with irritable bowel syndrome

Cruz RMA, Ortíz HRB, Muñiz JD, Padierna LJL

Language: Spanish
References: 27
Page: 29-33
PDF size: 42.99 Kb.


ABSTRACT

Introduction: The irritable bowel syndrome (SII) is characterized by alterations of intestinal motility and visceral sensibility, without organic cause. Is associated a psychiatric alterations and somatic symptoms in 80%, the anxiety or depression precede or is concomitants with gastrointestinal symptoms. Objective: To determine association between depression or anxiety on the basis of DSM-IV criteria and Scale of Hamilton in patients with criteria of Rome II. Design: A total one hundred patients were randomized in two groups: Hamilton for anxiety (n = 50) and DSM-IV for depression (n = 50), is correlated bi-variables (Pearson) in a descriptive and transversal study. Results: The female gender represented 76% (n = 76), the relation F/M; 4:1, the age average 49.7 years (R 18-89). Group DSM-IV in 62% (n = 31) had depression and 54% (n = 27) were women. The group Hamilton in 58% (n = 29) presented anxiety and 50% were women (n = 25). The correlation of Pearson (P ‹ 0.1) for the female with anxiety was of P ‹ 0.05 and in depression of P ‹ 0.01, using an IC 95%. Conclusions: The manifestation of anxiety or depression appears in more of 50%, affects in greater proportion the female, reason why antidepressing therapy must be contemplated in the handling of the SII.


REFERENCES

  1. Lacy B, Lee RD. Irritable bowel syndrome: a syndrome in evolution. J of Clin Gastroenterol 2005; 39 (Suppl.)3: 230-42.

  2. Schmulson MIII. Síndrome de intestino irritable: otra enfermedad sin base anatómica. Gac Méd Méx 2002; 138: 180-2.

  3. Boyce PM, Talley MJ, Burkey C. Epidemiology of the functional gastrointestinal disorders diagnosed according to Rome II criteria: an Australian population-based study. Inter Med J 2006; 36: 28-36.

  4. Pali-Hungin A, Tack J, Whorwell P. The truth in IBS (T-IBS) survey -an international study to assess the prevalence, epidemiology and impact of irritable bowel syndrome (IBS). Am J Gastroenterol 2001; 96: 318.

  5. Vaner SJ, Depew WT, Paterson WG. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol 1999; 94: 2912-17.

  6. Drossman DA, Camilleri M, Mayer E, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 2108-31.

  7. Posserud I, et al. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut 2004; 53: 1102-08.

  8. Weinryb R, et al. Psychological factors in irritable bowel syndrome: a population-based study of patients, non-patients and controls. Scand J Gastroenterol 2003; 38: 503-10.

  9. Lackner J. No brain, no gain. The role of cognitive processes in irritable bowel syndrome. J Cog Psych 2005; 19: 125-36.

  10. Lackner J. Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis. J Consul Clin Psy 2004; 72: 1100-13.

  11. Kuiken SD, Tytgat GN, Boeckstaens GE. Drugs interfering with visceral sensitivity for the treatment of functional gastrointestinal disorders-the clinical evidence. [Review] A Pharm & Ther 2005; 21: 633-51.

  12. Morgan V, et al. Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut 2005; 54: 601-7.

  13. Vahedi H, et al. The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study. Aliment Pharm Ther 2005; 22: 381-5.

  14. Sykes-Mark A, et al. Psychopathology in irritable bowel syndrome: support for a psychophysiological model. J Beh Med 2003; 26: 361-72.

  15. Henningsen P, et al. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psy Med 2003; 65: 528-33.

  16. Masand PS, et al. Major depression and irritable bowel syndrome: is there a relationship? J Clin Psychiatry 1995; 56: 363-7.

  17. Garakani-Amir, et al. Comorbidity of irritable bowel syndrome in psychiatric patients: a review. Am J Ther 2003; 10: 61-7.

  18. Posserud I, et al. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut 2004; 53: 1102-8.

  19. Tone-Tangen H, Arnstein M, Dahl A. The association between anxiety, depression, and somatic symptoms in a large population. The HUNT-II Study. Psy Med 2004; 66: 845-851.

  20. López-Alvarenga JC, et al. Exactitud y utilidad diagnóstica del hospital de la escala de ansiedad y depresión hospitalaria (ADM) en una muestra de sujetos obesos mexicanos. Rev Invest Clín 2002; 54: 403-9.

  21. Lydiar RB, et al. Prevalence of psychiatry disorders in patients with irritable bowel syndrome. Psychosomatics 1993; 34: 229-34.

  22. Katon W. Panic disorder and medical comorbidity: a review of the medical and psychiatric literature. Bull Menninger Clinic 1996; 60(Suppl.): 13-14.

  23. Bonet JL, Luchia C. Psiconeuro-inmunoendocrinología. Rev Arg Psiq 1995: 6(21).

  24. Lackner JM, Lou Coad M, Mertz HR, Wack DS. Cognitive therapy for irritable bowel syndrome is associated with reduced limbic activity, GI symptoms, and anxiety. Behav Res Ther 2006; 44: 621-38.

  25. Walker E, et al. Irritable bowel syndrome and psychiatric illness. Am J Psychiatric 1990; 147: 565-72.

  26. Farthing MJ. Irritable bowel, irritable body, or irritable brain? B Med Journal 1995; 310: 171-5.

  27. Andrews B, Hejdenberg J, Wilding J. Student anxiety and depression: comparison of questionnaire and interview assessments. J Affect Disord 2006; 95: 29-34.




2020     |     www.medigraphic.com